相关实验视频
Updated: May 30, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.0K
在DSS诱导的IBD小鼠模型中,SAA3缺乏会加剧肠道纤维化
Xiaodong Zou1,2, Tong Wu3, Jianjiao Lin1
1Department of Gastroenterology, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.
Cell death discovery
|January 25, 2025
概括
血清粉样蛋白A3 (SAA3) 缺乏在炎症性肠病 (IBD) 模型中恶化肠纤维化. 纤维细胞中的SAA3遗传干扰通过特定的信号级联加剧纤维化,表明治疗潜力.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 肠道纤维化是炎症性肠病 (IBD) 的严重并发症,通常需要手术并降低患者的生活质量.
- 血清粉样蛋白A3 (SAA3) 是一种急性阶段蛋白质,与纤维化过程有关,尽管其在肠道纤维化中的确切作用尚不清楚.
研究的目的:
- 在IBD小鼠模型中调查SAA3在肠道纤维化发展中的作用.
- 阐明SAA3影响纤维细胞激活和纤维细胞进展的分子机制.
主要方法:
- 使用硫酸德克斯 (DSS) 建立了IBD和肠纤维化的小鼠模型.
- 在SAA3缺乏小鼠与野生类型对照中的肠道纤维化的严重程度进行了比较.
- 分析了SAA3遗传干扰对纤维细胞激活和HSPB1/NF-κB/TGF-β1/Smads信号通路的影响.
主要成果:
- 与对照组相比,SAA3缺乏的小鼠表现出明显更严重的肠道纤维化.
- 纤维细胞中SAA3的遗传破坏导致了对肌纤维细胞的增强激活.
- 这种激活是由HSPB1/NF-κB/TGF-β1/Smads信号级联介导的,导致纤维化恶化.
结论:
- 在减轻与IBD相关的肠道纤维化方面,SAA3起着保护作用.
- 了解SAA3的调节机制为治疗IBD相关的肠纤维化提供了潜在的治疗点.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
310
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
310
Chronic Bowel Disorders: Introduction
385
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
385
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118

